Science,
in connection.
Independent scientific counsel across molecular diagnostics, clinical evidence, and laboratory practice.
Work directly with Dr. Sunil D. Pandit,
Ph.D., MB(ASCP).
One question.
A connected view.
The assay. The biomarker. The intended use.
Connect the biological question to what can be measured, and how the assay will be developed and validated.
Diagnostic development
Assay design, IVD/LDT development, validation, and design controls.
Biomarker strategy
Clinical biomarker programs, NGS, liquid biopsy, and spatial omics.
A useful starting question
What must the assay measure, in which specimen, for what intended use?
The evidence behind the next decision.
Bring the assay, clinical question, and available evidence into the same conversation.
Translational medicine
Clinical-trial assays, precision medicine, and integration of multiple clinical-data types.
Regulatory submissions
Scientific evidence and planning support for 510(k), PMA, and IDE submissions.
A useful starting question
What evidence is available, and what decision or next milestone must it support?
Where scientific plans become practice.
Consider the laboratory as a connected operation: capabilities, people, workflows, and quality systems.
CLIA laboratory setup
Laboratory design, quality systems, and accreditation planning.
Global laboratory operations
Laboratory networks, operational strategy, and quality and compliance planning.
A useful starting question
What capabilities and quality systems must the laboratory support?
Your selected area is included with your request.
A conceptual map of molecular, clinical, and laboratory work.
Independent consulting since 2016
Dr. Sunil D. Pandit
Ph.D., MB(ASCP)
More than two decades working across molecular diagnostics, precision medicine, and clinical laboratory leadership.
Dr. Pandit’s experience connects IVD development under design control, biomarker assays for oncology and infectious disease, and the operations that support scientific programs.
At Neobiolinus, that experience comes directly into your conversation.
Scientific background
Selected prior roles
- 2024 – June 2025
Precision for Medicine
Senior Scientific Director · Global Operations
- 2022 – 2024
Parexel
Senior Scientific Director · Precision and Genomic Medicine
- 2019 – 2020
Biogen
Director · Diagnostics Pathways
- 2017 – 2019
GSK
Director · Precision Medicine and Companion Diagnostics
- 2015 – 2017
Affymetrix
Director · Clinical Science
- 2007 – 2014
Siemens Healthcare Diagnostics
Senior Manager · Molecular and Companion Diagnostics
Additional experience includes U.S. CEO and CLIA laboratory director at AnPac Bio, CLIA laboratory director at VircoLabs (Janssen Diagnostics), and scientific roles at the National Institutes of Health.
Education and research training
- Ph.D., Biochemistry and Molecular Biology
- State University of New York at Stony Brook
- Postdoctoral research, Human Molecular Genetics
- Washington University School of Medicine, St. Louis
- M.Tech., Biochemical Engineering and Biotechnology
- Indian Institute of Technology, Delhi
- M.Sc., Chemistry
- Indian Institute of Technology, Delhi
Selected patent
contributions.
Dr. Pandit is named as a co-inventor on these records. They name Siemens Healthcare Diagnostics Inc. as assignee.
Reagents and methods for analysis of HIV
(opens original patent record in a new tab)U.S. Patent 10,851,428Granted
Prefixation for increased rare cell recovery
(opens original patent record in a new tab)U.S. Patent 10,564,075Granted
Reagents and methods for detecting HCV
(opens original patent record in a new tab)U.S. Patent 10,982,294Granted